Search

Your search keyword '"M.A. Di Nolfo"' showing total 26 results

Search Constraints

Start Over You searched for: Author "M.A. Di Nolfo" Remove constraint Author: "M.A. Di Nolfo"
26 results on '"M.A. Di Nolfo"'

Search Results

1. 109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B)

2. OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B)

Catalog

Books, media, physical & digital resources

3. 1039 ALPHAFETOPROTEIN AND TRANSPLANT SURVIVAL BENEFIT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTRE COHORT STUDY

4. 960 HEPATOCELLULAR CARCINOMA (HCC) IN HCV-RELATED CIRRHOSIS: A 20-YEARS SURVEY BY ITA.LI.CA

5. 1003 THE EVOLVING CLINICAL SCENARIO OF HEPATOCELLULAR CARCINOMA OVER THE LAST 20 YEARS IN ITALY

6. Semiannual versus annual surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma: Is there a winner?

8. 817 SEMIANNUAL VERSUS ANNUAL SURVEILLANCE OF CIRRHOTIC PATIENTS FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IS THERE A WINNER?

9. LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK

10. INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE?

11. T-40 Alphafetoprotein and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre cohort study

12. T-2 The evolving clinical scenario of hepatocellular carcinoma over the last 20 years in Italy

13. T-4 A 20-years survey by ITA.LI.CA on hepatocellular carcinoma (HCC) in HCV-related cirrhosis

14. 789 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK

15. OC2.01.2 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLULAR CARCINOMA: WHEN IS IT WORTH DOING?

16. [274] SURVEILLANCE FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IS IT EFFECTIVE IN INTERMEDIATE/ADVANCED CIRRHOSIS?

17. Surveillance for early diagnosis of hepatocellular carcinoma (HCC): Is it effective in intermediate/advanced cirrhosis?

18. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

19. Diagnostic and Prognostic Role of alpha-Fetoprotein in Hepatocellular Carcinoma: Both or Neither?

20. Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study

21. Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma

22. Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study

23. Surveillance for early diagnosis of hepatocellular carcinoma (HCC): is it effective in intermediate/advanced cirrhosis. Digest. Liver Dis., 39 (3): A3, 2007

24. Results of treatment for hepatocellular carcinoma in elderly patients: comparison with a younger population. Int. Emerg. Med., 2 (suppl.): S23, 2007 (Premio SIMI 2007)

25. Impact of etiology of cirrhosis on HCC stage and on survival of patients under surveillance

26. Prevalence and prognostic meaning of the presence of oesophageal varices in patients with hepatocellular carcinoma